142 related articles for article (PubMed ID: 37088659)
21. Clinical outcome and predictors of survival in late relapse of germ cell tumor.
Sharp DS; Carver BS; Eggener SE; Kondagunta GV; Motzer RJ; Bosl GJ; Sheinfeld J
J Clin Oncol; 2008 Dec; 26(34):5524-9. PubMed ID: 18936477
[TBL] [Abstract][Full Text] [Related]
22. Management of residual disease after chemotherapy in germ cell tumors.
King J; Adra N; Einhorn LH
Curr Opin Oncol; 2020 May; 32(3):250-255. PubMed ID: 32168037
[TBL] [Abstract][Full Text] [Related]
23. Primary tumor size thresholds in stage IA testicular seminoma: Implications for adjuvant therapy after orchiectomy and survival.
Azizi M; Peyton CC; Boulware DC; Gilbert SM; Sexton WJ
Urol Oncol; 2020 Jan; 38(1):7.e9-7.e18. PubMed ID: 31704139
[TBL] [Abstract][Full Text] [Related]
24. Postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) for seminoma: Limitations of surgical intervention after first-line chemotherapy.
Tachibana I; Alabd A; Whaley RD; McFadden J; Piroozi A; Hassoun R; Kern SQ; King J; Adra N; Rice KR; Foster RS; Einhorn LH; Cary C; Masterson TA
Urol Oncol; 2023 Sep; 41(9):394.e1-394.e6. PubMed ID: 37543446
[TBL] [Abstract][Full Text] [Related]
25. Late Relapses in Stage I Testicular Cancer Patients on Surveillance.
Mortensen MS; Lauritsen J; Kier MG; Bandak M; Appelt AL; Agerbæk M; Holm NV; Kempel MM; von der Maase H; Daugaard G
Eur Urol; 2016 Aug; 70(2):365-71. PubMed ID: 26996661
[TBL] [Abstract][Full Text] [Related]
26. Metachronous bilateral testicular germ cell tumors: report of two cases.
James FV; Kumar A; Jayaprakash PG; Mathews A
J Cancer Res Ther; 2009; 5(3):206-7. PubMed ID: 19841564
[TBL] [Abstract][Full Text] [Related]
27. Histological outcome of delayed orchidectomy after primary chemotherapy for metastatic germ cell tumour of the testis.
Ramani VA; Grey BR; Addla SK; Dunham MP; Sangar VK; Clarke NW
Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):247-52. PubMed ID: 18093814
[TBL] [Abstract][Full Text] [Related]
28. Late recurrences of germ cell malignancies: a population-based experience over three decades.
Oldenburg J; Alfsen GC; Waehre H; Fosså SD
Br J Cancer; 2006 Mar; 94(6):820-7. PubMed ID: 16508636
[TBL] [Abstract][Full Text] [Related]
29. Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS).
Rothermundt C; Thurneysen C; Cathomas R; Müller B; Mingrone W; Hirschi-Blickenstorfer A; Wehrhahn T; Ruf C; Rothschild S; Seifert B; Terbuch A; Grassmugg T; Woelky R; Fankhauser C; Kunit T; Fischer N; Inauen R; Kamradt J; Ziegler K; Haynes A; Jüni P; Gillessen S
Swiss Med Wkly; 2018; 148():w14640. PubMed ID: 30044478
[TBL] [Abstract][Full Text] [Related]
30. Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: Results from the IGCCCG Update Consortium.
Bührer E; D'Haese D; Daugaard G; de Wit R; Albany C; Tryakin A; Fizazi K; Stahl O; Gietema JA; De Giorgi U; Cafferty FH; Hansen AR; Tandstad T; Huddart RA; Necchi A; Sweeney CJ; Garcia-Del-Muro X; Heng DYC; Lorch A; Chovanec M; Winquist E; Grimison P; Feldman DR; Terbuch A; Hentrich M; Bokemeyer C; Negaard H; Fankhauser C; Shamash J; Vaughn DJ; Sternberg CN; Heidenreich A; Collette L; Gillessen S; Beyer J
Eur J Cancer; 2024 May; 202():114042. PubMed ID: 38564927
[TBL] [Abstract][Full Text] [Related]
31. Pathologic findings and clinical outcomes in patients who required neoadjuvant chemotherapy before orchiectomy for testicular germ cell tumors.
Stump JA; Acosta AM; Whaley RD; Cheng L; Fang AM; Rais-Bahrami S; Gordetsky JB
Hum Pathol; 2022 Oct; 128():48-55. PubMed ID: 35817140
[TBL] [Abstract][Full Text] [Related]
32. Impact of primary metastatic bone disease in germ cell tumors: results of an International Global Germ Cell Tumor Collaborative Group G3 Registry Study.
Oing C; Oechsle K; Necchi A; Loriot Y; De Giorgi U; Fléchon A; Daugaard G; Fedyanin M; Faré E; Bokemeyer C
Ann Oncol; 2017 Mar; 28(3):576-582. PubMed ID: 27993806
[TBL] [Abstract][Full Text] [Related]
33. Surveillance policy for Japanese patients with stage I testicular germ cell cancer in the multi-detector computed tomography era.
Yuasa T; Inoshita N; Tanaka H; Urakami S; Yamamoto S; Fujii Y; Masuda H; Fukui I; Ishikawa Y; Yonese J
Int J Clin Oncol; 2015 Dec; 20(6):1198-202. PubMed ID: 25893862
[TBL] [Abstract][Full Text] [Related]
34. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
35. How to classify, diagnose, treat and follow-up extragonadal germ cell tumors? A systematic review of available evidence.
Winter C; Zengerling F; Busch J; Heinzelbecker J; Pfister D; Ruf C; Lackner J; Albers P; Kliesch S; Schmidt S; Bokemeyer C
World J Urol; 2022 Dec; 40(12):2863-2878. PubMed ID: 35554637
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathological features and survival of testicular tumours in a Southeast Asian university hospital: a ten-year review.
Tan GH; Azrif M; Shamsul AS; Ho CC; Praveen S; Goh EH; Bahadzor B; Ismail F; Zulkifli MZ
Asian Pac J Cancer Prev; 2011; 12(10):2727-30. PubMed ID: 22320982
[TBL] [Abstract][Full Text] [Related]
37. A multi-center prospective phase II study of high-dose chemotherapy in germ-cell cancer patients relapsing from complete remission.
Rodenhuis S; de Wit R; de Mulder PH; Keizer HJ; Sleijfer DT; Lalisang RI; Bakker PJ; Mandjes I; Kooi M; de Vries EG
Ann Oncol; 1999 Dec; 10(12):1467-73. PubMed ID: 10643538
[TBL] [Abstract][Full Text] [Related]
38. Treatment outcome and long-term follow-up of central nervous system germ cell tumor using upfront chemotherapy with subsequent photon or proton radiation therapy: a single tertiary center experience of 127 patients.
Hong KT; Lee DH; Kim BK; An HY; Choi JY; Phi JH; Cheon JE; Kang HJ; Kim SK; Kim JY; Park SH; Kim IH; Shin HY
BMC Cancer; 2020 Oct; 20(1):979. PubMed ID: 33036578
[TBL] [Abstract][Full Text] [Related]
39. Survival outcomes and toxicity in patients 40 years old or older with relapsed metastatic germ cell tumors treated with high-dose chemotherapy and peripheral blood stem cell transplantation.
Agrawal V; Abonour R; Abu Zaid M; Althouse SK; Ashkar R; Albany C; Hanna NH; Einhorn LH; Adra N
Cancer; 2021 Oct; 127(20):3751-3760. PubMed ID: 34260067
[TBL] [Abstract][Full Text] [Related]
40. Primary Mediastinal Germ Cell Tumors-The University of Western Ontario Experience.
Lavi A; Winquist E; Nair SM; Chin JL; Izawa J; Fernandes R; Ernst S; Power NE
Curr Oncol; 2020 Dec; 28(1):78-85. PubMed ID: 33704177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
